{"id":"W2808572932","doi":"10.3747/co.25.3750","title":"Current Landscape of Immunotherapy for the Treatment of Metastatic Non-Small-Cell Lung Cancer","year":2018,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Peking University; Peking University People's Hospital; National Natural Science Foundation of China","keywords":"Pembrolizumab; Atezolizumab; Medicine; Nivolumab; Immunotherapy; Lung cancer; Oncology; Chemotherapy; Internal medicine; Clinical trial; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003576053,0.0004814646,0.002673682,0.0002120198,0.00006439195,0.0000060742,0.0002996758,0.0001781856,0.0003457332],"category_scores_gemma":[0.00001255903,0.0002582054,0.001518622,0.0002996231,0.0002587911,0.00001541007,0.000024401,0.0001864053,0.000004123499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005592678,"about_ca_system_score_gemma":0.001878416,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005473251,"about_ca_topic_score_gemma":0.00004362138,"domain_scores_codex":[0.9977793,0.0001505738,0.001145042,0.0003944037,0.0001801609,0.0003504845],"domain_scores_gemma":[0.9971009,0.0007510556,0.001229243,0.0006147243,0.0002397515,0.00006435581],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008917776,0.001997541,0.0001170758,0.02757581,0.002256659,9.983404e-7,0.000536481,1.944062e-7,0.00001264239,0.000003818108,0.005783664,0.9608234],"study_design_scores_gemma":[0.006030793,0.003525314,0.00003579972,0.009314721,0.007304231,0.00001309977,0.00004526057,0.00006162851,0.00006767621,0.000003131964,0.9733915,0.0002068303],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003288911,0.9897527,0.0003317286,0.00005758449,0.004219445,0.004794148,0.0004281316,0.00001213832,0.00007530639],"genre_scores_gemma":[0.00001978528,0.9965128,0.0001407892,0.00001478609,0.0006537551,0.002226226,0.0002009254,0.00006213014,0.000168818],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9676079,"threshold_uncertainty_score":0.999987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1612086509722732,"score_gpt":0.4704134536338138,"score_spread":0.3092048026615407,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}